Dr.
Horovitz was most recently Vice President, Business Development
and Planning, Bristol-Myers Squibb. Prior to this assignment,
he was involved in various positions which included research
and administration. He has successfully consummated several
acquisitions for BMS, as well as aligned BMS with meaningful
strategic partners. He is currently serving on the board of
Synaptic Corp., Avigen Corp., Phyton, Inc., Vivante International,
Biocryst Pharmaceuticals, Diacrin, Inc., Procept Corp., InfoMed
Holdings, Inc., and Nitromed.